Hogan Lovells has advised HealthCare Royalty Partners. Goodwin has advised Apnimed, Inc. Apnimed, Inc., a pharmaceutical company focused on developing oral therapies for obstructive sleep apnea...
Apnimed Secures $150 Million Debt Financing and Monetizes SASS Joint Venture Stake
Apnimed’s Extended Series C Financing Round
Troutman Pepper Hamilton Sanders advised Apnimed on the deal. Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA)...
Apnimed’s Series C Financing
Troutman Pepper advised Apnimed on the deal. Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related...
Apnimed’s $25 Million Series B Financing
Troutman Pepper Hamilton Sanders LLP advised Apnimed on the deal. Apnimed, a clinical-stage company focused on advancing pharmacologic treatments for sleep apnea and related disorders, has...